Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 87 -2 (-2.25%) Aug 14
At Loss
P/B:
9.55
Market Cap:
€ 7.92B ($ 9.16B)
Enterprise V:
€ 7.05B ($ 8.16B)
Volume:
0
Avg Vol (2M):
125.00
Trade In:

Spyre Therapeutics Inc Operating Data

Spyre Therapeutics Inc Competitors' Latest Operating Data

Operating data not available.

Spyre Therapeutics Inc (FRA:3920) Operating Data Charts